TUB Stock Overview
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Financière de Tubize SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €118.40 |
| 52 Week High | €156.00 |
| 52 Week Low | €93.20 |
| Beta | 0.43 |
| 1 Month Change | -8.50% |
| 3 Month Change | -21.28% |
| 1 Year Change | 25.16% |
| 3 Year Change | 25.96% |
| 5 Year Change | 73.35% |
| Change since IPO | 2,013.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| TUB | BE Pharmaceuticals | BE Market | |
|---|---|---|---|
| 7D | 7.4% | 1.8% | 1.8% |
| 1Y | 25.2% | -18.2% | 3.0% |
Return vs Industry: TUB exceeded the Belgian Pharmaceuticals industry which returned -18.2% over the past year.
Return vs Market: TUB exceeded the Belgian Market which returned 3% over the past year.
Price Volatility
| TUB volatility | |
|---|---|
| TUB Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BE Market | 8.5% |
| 10% least volatile stocks in BE Market | 2.6% |
Stable Share Price: TUB's share price has been volatile over the past 3 months compared to the Belgian market.
Volatility Over Time: TUB's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Belgian stocks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1928 | n/a | Eric Nys | www.financiere-tubize.be |
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.
Financière de Tubize SA Fundamentals Summary
| TUB fundamental statistics | |
|---|---|
| Market cap | €5.27b |
| Earnings (TTM) | €90.10m |
| Revenue (TTM) | €13.26k |
58.5x
P/E RatioOver9,999x
P/S RatioIs TUB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TUB income statement (TTM) | |
|---|---|
| Revenue | €13.26k |
| Cost of Revenue | €2.24m |
| Gross Profit | -€2.22m |
| Other Expenses | -€92.33m |
| Earnings | €90.10m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Aug 02, 2025
| Earnings per share (EPS) | 2.02 |
| Gross Margin | -16,767.63% |
| Net Profit Margin | 679,673.60% |
| Debt/Equity Ratio | 2.2% |
How did TUB perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield51%
Payout RatioDoes TUB pay a reliable dividends?
See TUB dividend history and benchmarks| Financière de Tubize dividend dates | |
|---|---|
| Ex Dividend Date | Apr 30 2025 |
| Dividend Pay Date | May 05 2025 |
| Days until Ex dividend | 3 days |
| Days until Dividend pay date | 8 days |
Does TUB pay a reliable dividends?
See TUB dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/27 07:42 |
| End of Day Share Price | 2025/04/25 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Financière de Tubize SA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marc Debrouwer | Degroof Petercam |